Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: A molecular classification with implications for targeted therapies

Blood

Volumn 119, Issue 19, 2012, Pages 4467-4475

  Agathangelidis, Andreas ^a   Darzentas, Nikos ^a   Hadzidimitriou, Anastasia ^a   Brochet, Xavier ^b   Murray, Fiona ^c   Yan, Xiao Jie ^d   Davis, Zadie ^e   Van Gastel Mol, Ellen J ^f   Tresoldi, Cristina ^g   Chu, Charles C ^d   Cahill, Nicola ^h   Giudicelli, Veronique ^b   Tichy, Boris ⁱ   Pedersen, Lone Bredo ^j   Foroni, Letizia ^k   Bonello, Lisa ^l   Janus, Agnieszka ^m   Smedby, Karin ^c   Anagnostopoulos, Achilles ⁿ   Merle Beral, Helene ^o   Laoutaris, Nikolaos ^p   Juliusson, Gunnar ^q   Di Celle, Paola Francia ^l   Pospisilova, Sarka ⁱ   Jurlander, Jesper ^j   Geisler, Christian ^j   Tsaftaris, Athanasios ^a   Lefranc, Marie Paule ^b   Langerak, Anton W ^f   Oscier, David Graham ^e   Chiorazzi, Nicholas ^d   Belessi, Chrysoula ^p   Davi, Frederic ^o   Rosenquist, Richard ^h   Ghia, Paolo ^m   Stamatopoulos, Kostas ^a,n   more..

^a INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^b UMR 9002 CNRS UM   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^j Rigshospitalet   (Denmark)

^k HAMMERSMITH HOSPITAL   (United Kingdom)

^l MOLINETTE HOSPITAL   (Italy)

^m VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

ⁿ G PAPANICOLAOU HOSPITAL   (Greece)

^o SORBONNE UNIVERSITÉ   (France)

^p GENERAL HOSPITAL OF NIKEA   (Greece)

^q LUND UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY VARIABLE; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; CANCER PATIENT; CELL COMPARTMENTALIZATION; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; DISEASE CLASSIFICATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; ONTOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEREOTYPY;

EID: 84861033763     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-393694     Document Type: Article

References (50)

1. Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today. 1994;15(6): 288-294. (Pubitemid 24170523)
2. Hashimoto S, Dono M, Wakai M, et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med. 1995;181(4):1507-1517.
3. Efremov DG, Ivanovski M, Siljanovski N, et al. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood. 1996;87(9): 3869-3876.
4. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158(1):235-246. (Pubitemid 127483861)
5. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102(8):1515-1525. (Pubitemid 28492218)
6. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840-1847. (Pubitemid 29430399)
7. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848-1854. (Pubitemid 29430400)
8. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 2002;99(6):2262-2264. (Pubitemid 34525519)
9. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003; 101(12):4952-4957. (Pubitemid 36857759)
10. Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004;113(7):1008-1016. (Pubitemid 38544122)
11. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004; 200(4):519-525. (Pubitemid 39121908)
12. Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004;104(8):2499-2504. (Pubitemid 39331853)
13. Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 2004;104(9):2879- 2885. (Pubitemid 39434975)
14. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood. 2007;109(1):259-270. (Pubitemid 46070124)
15. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 2008;111(3):1524-1533. (Pubitemid 351213442)
16. Bomben R, Dal Bo M, Capello D, et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol. 2009;144(4):492-506.
17. Darzentas N, Hadzidimitriou A, Murray F, et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia. 2010;24(1):125-132.
18. Herve M, Xu K, Ng YS, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest. 2005; 115(6):1636-1643. (Pubitemid 40814672)
19. Lanemo Myhrinder A, Hellqvist E, Sidorova E, et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008;111(7):3838-3848.
20. Catera R, Silverman GJ, Hatzi K, et al. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med. 2008;14(11-12):665-674.
21. Chu CC, Catera R, Hatzi K, et al. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood. 2008;112(13): 5122-5129.
22. Chu CC, Catera R, Zhang L, et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood. 2010;115(19):3907-3915.
23. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12): 5446-5456.
24. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317. (Pubitemid 38072572)
25. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 2009;37(Database issue):D1006-D1012.
26. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008;36(Web Server issue): W503-W508.
27. Lefranc MP, Pommie C, Ruiz M, et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily Vlike domains. Dev Comp Immunol. 2003;27(1): 55-77. (Pubitemid 35449624)
28. Kirkham PM, Mortari F, Newton JA, SchroederHWJr. Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J. 1992;11(2):603-609.
29. Pommie C, Levadoux S, Sabatier R, Lefranc G, Lefranc MP. IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J Mol Recognit. 2004; 17(1):17-32. (Pubitemid 38231461)
30. Giudicelli V, Duroux P, Ginestoux C, et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res. 2006;34(Database issue):D781-D784.
31. Hadzidimitriou A, Agathangelidis A, Darzentas N, et al. Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood. 2011;118(11):3088-3095.
32. Zibellini S, Capello D, Forconi F, et al. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica. 2010; 95(10):1792-1796.
33. Bikos V, Darzentas N, Hadzidimitriou A, et al. Over 30% of patients with splenic marginal zone lymphoma express distinctive antigen receptors utilizing a single immunoglogulin variable gene: implications for the origin and selection of the neoplastic cells [abstract]. Blood (ASH Annual Meeting Abstracts). 2010;116:Abstract 634.
34. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8): 804-815.
35. Forconi F, Potter KN, Wheatley I, et al. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood. 2010;115(1):71-77.
36. Berkowska MA, Driessen GJ, Bikos V, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 2011;118(8):2150-2158.
37. Kuroda D, Shirai H, Kobori M, Nakamura H. Structural classification of CDR-H3 revisited: a lesson in antibody modeling. Proteins. 2008; 73(3):608-620. (Pubitemid 352788644)
38. Ehrenmann F, Kaas Q, Lefranc MP. IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res. 2010;38(Database issue): D301-D307.
39. Barrios Y, Jirholt P, Ohlin M. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit. 2004;17(4):332-338. (Pubitemid 38893601)
40. Zemlin M, Klinger M, Link J, et al. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol. 2003;334(4):733-749. (Pubitemid 37433888)
41. Silverman GJ, Goodyear CS. Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat Rev Immunol. 2006;6(6):465-475.
42. Jirholt P, Ohlin M, Borrebaeck CA, Soderlind E. Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework. Gene. 1998;215(2):471-476. (Pubitemid 28382951)
43. Scheid JF, Mouquet H, Ueberheide B, et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science. 2011;333(6049):1633-1637.
44. Kostareli E, Gounari M, Janus A, et al. Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity [published online ahead of print November 4, 2011]. Leukemia. doi:10.1038/leu.2011.3112011.
45. Jirholt P, Strandberg L, Jansson B, et al. A central core structure in an antibody variable domain determines antigen specificity. Protein Eng. 2001; 14(1):67-74. (Pubitemid 32318939)
46. Johnson G, Wu TT. Preferred CDRH3 lengths for antibodies with defined specificities. Int Immunol. 1998;10(12):1801-1805. (Pubitemid 28566041)
47. Hardy RR. B-1 B cell development. J Immunol. 2006;177(5):2749-2754. (Pubitemid 44277787)
48. Hatzi K, Catera R, Ferrarini M, et al. B-cell chronic lymphocytic leukemia (B-CLL) cells express antibodies reactive with antigenic epitopes expressed on the surface of common bacteria. Blood. 2006;108(11):12a.
49. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med. 2011;208(1): 67-80.
50. Rossi D, Spina V, Cerri M, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res. 2009;15(13): 4415-4422.